- Home
- WBX vs FBIO Comparison
WBX vs FBIO Comparison
Compare WBX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WBX | FBIO |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 113.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WBX | FBIO |
|---|---|---|
| Price | $3.01 | $3.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $9.00 | ★ $16.50 |
| AVG Volume (30 Days) | 34.2K | ★ 1.2M |
| Earning Date | 02-26-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $174,593,453.00 | $62,303,000.00 |
| Revenue This Year | N/A | $29.71 |
| Revenue Next Year | $37.11 | $49.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $1.33 |
| 52 Week High | $12.30 | $4.53 |
Technical Indicators
Market Signals| Indicator | WBX | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 47.17 |
| Support Level | $2.84 | $3.33 |
| Resistance Level | $3.13 | $3.79 |
| Average True Range (ATR) | 0.17 | 0.33 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 85.54 | 18.36 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.